ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Long-Term Persistence of Recipient MHC Class-II Antigen Following Allogeneic Bone Marrow Transplantation

T. Brennan, L. Lin, Y. Yang

Surgery, Duke University, Durham, NC
Medicine and Immunology, Duke University, Durham, NC

Meeting: 2013 American Transplant Congress

Abstract number: C1163

Background: Following allogeneic bone marrow transplantation there is rapid replacement of host antigen presenting cells with donor antigen presenting cells. This has important implications of the mechanisms of alloantigen presentation that results in graft-vs-host disease (GVHD). However, the kinetics of this process are not well understood.

Methods: Lethally irradiated BALB/c mice were the recipients of 10^7 B6 bone marrow and 10^6 B6 lymphocytes by intravenous injection. This model leads to lethal GVHD in 3 to 4 wks. On a weekly basis, bone marrow recipients were injected with 2×10^6 CFSE-labelled, purified CD4+ T cells from 4C T cell receptor transgenic mouse. The 4C mouse has CD4+ T cells with direct alloreactivity against the BALB/c MHC-class II molecule, I-Ad. Three days after injection, splenocytes and intrahepatic lymphocytes were purified and analyzed by FACS. Transferred 4C T cells were identified in host mice by as Ly5.1+, CD4+ cells. Lymphocytes obtained from host mice were analyzed by FACS for host vs. donor MHC expression at various time points after transplantation.

Results: Even at late time points, when host antigen presenting cells are undetectable by histology or FACS, 4C T cells proliferate robustly in BALB/c recipients of B6 bone marrow transplantation, even with the addition of lethal amount of allogeneic lymphocytes. FACS analysis of host lymphocytes demonstrates a substantial population with mixed host and donor MHC molecules.

Conclusions: These results demonstrate that direct CD4+ alloantigen recognition occurs at late time points following allo-BMT. Lymphocytes with donor and host mixed MHC expression, potentially obtained through the process of trogocytosis, may account for an unrecognized pool of host alloantigen that can lead to late onset acute GVHD.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Brennan T, Lin L, Yang Y. Long-Term Persistence of Recipient MHC Class-II Antigen Following Allogeneic Bone Marrow Transplantation [abstract]. Am J Transplant. 2013; 13 (suppl 5). https://atcmeetingabstracts.com/abstract/long-term-persistence-of-recipient-mhc-class-ii-antigen-following-allogeneic-bone-marrow-transplantation/. Accessed May 14, 2025.

« Back to 2013 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences